Safety of Cartrophen Vet in the dog: Review of adverse reaction reports in the UK

Journal of Small Animal Practice

Volumn 44, Issue 5, 2003, Pages 202-208

  Hannon, R L ^a   Smith, J G ^a   Cullis Hill, D ^a   Ghosh, P ^b   Hope Cawdery, M J ^c  

^a Biopharma Pty Ltd   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c Arthropharm (Europe)   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN; PENTOSAN POLYSULFATE; CARBAZOLE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

DEPRESSION; DOG; DOSE CALCULATION; DRUG SAFETY; LETHARGY; NONHUMAN; REVIEW; VOMITING; ANIMAL; ANIMAL DISEASE; ARTICLE; BREEDING; DOG DISEASE; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; OSTEOARTHRITIS; RISK ASSESSMENT; STATISTICS; UNITED KINGDOM;

CANIS FAMILIARIS; EMESIS; UNCLASSIFIED ORGANISMS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREEDING; CARBAZOLES; DOG DISEASES; DOGS; DRUG INTERACTIONS; GREAT BRITAIN; OSTEOARTHRITIS; PENTOSAN SULFURIC POLYESTER; RISK ASSESSMENT;

EID: 0037564027     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.2003.tb00144.x     Document Type: Review

References (36)

1. BATALLER, N. & KELLER, W. C. (1999) Monitoring of adverse reactions to veterinary drugs. Veterinary Clinics of North America: Food Animal Practice 15, 13-30
2. BENNETT, D. & MAY, C. (1995) Joint diseases of dogs and cats. In: Textbook of Veterinary Internal Medicine. Ed S. J. Ettinger. W. B. Saunders, Philadelphia pp 2053-2059
3. BOUCK, G R , MILLER, C. W. & TAVES, C. L. (1995) A comparison of surgical and medical treatments of fragmented coronoid process and osteochondritis dissecans of the canine elbow. Veterinary and Comparative Orthopaedics and Traumatology 8, 177-183
4. BRUNNEE, T., REDDIGARI, S. R., SHIBAYAMA, Y., KAPLAN, A. P. & SILVERBEBG, M (1997) Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions. Clinical and Experimental Allergy 27, 653-663
5. BURKHARDT, D. & GHOSH, P. (1987) Laboratory evaluation of anti-arthritic drugs as potential chondroprotective agents. Seminars in Arthritis and Rheumatism 17 Supplement 1, 3-34
6. DEGENHARDT, M., GHOSH, P. & WATZIG, H. (2001) Studies on the structural variations of pentosan polysulfate sodium (NaPPS) from different sources by capillary electrophoresis. Archive der Pharmazie - Pharmaceutical and Medicinal Chemistry 334, 27-29
7. DOUGADOS, M., DEVOGELAER, J. P., ANNEFELDT, M., AVOUAC, B., BOUVENOT, G., COOPER, C , DIEPPE, P., ETHGEN, D., GARATTINI, S. & JONES, E. A. (1996) Recommendations for the registration of drugs used in the treatment of osteoarthritis. Annals of the Rheumatic Diseases 55, 552-557
8. DOUGLAS, W. W. (1980) Polypeptides - angiotensin, plasma kinins and others. In: Goodman and Gilman's The Pharmalogical Basis of Therapeutics, 6th edn. Eds A. G. Gilman, L. S. Goodman and A. Gilman. Macmillan Publishing, New York. pp 647-681
9. GARDNER, D. L. (1983) The nature and causes of osteoarthrosis. British Medical Journal 286, 418-424
10. GHOSH, P. (1991) Osteoarthritis: aetiopathogenesis and management. Modern Medicine Australia 68, 68-80
11. GHOSH, P. (1999) The pathobioiogy of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Seminars in Arthritis and Rheumatism 28, 211-267
12. HALLIKAINEN, A. (1994) The use of pentosan polysulphate sodium in the treatment of musculoskeletal disease in the dog - an open clinical study. Graduate thesis. University of Helsinki, Finland
13. HAMERMAN, D. (1993) Aging and osteoarthritis: Basic mechanisms. Journal of the American Geriatrics Society 41, 760-770
14. HAY, L. E. (1992) The use of pentosan polysulphate following the repair of cranial cruciate ligament rupture in dogs. MSc Thesis. Murdoch University, Perth, Western Australia
15. HAY, L. E. (1992) The use of pentosan polysulphate following the repair of cranial cruciate ligament rupture in dogs. MSc Thesis. Murdoch University, Perth, Western Australia
16. HOJIMA, Y., COCHRANE, C. G., WIGGINS, K. F. & STEVENS, R. L. (1984) In vitro activation of the contact (Hageman Factor) system of plasma by heparin and chondroitin sulfate E. Blood 63, 1453-1459
17. HULSE, D. (1998) Treatment methods for pain in the osteoarthritic patient. Veterinary Clinics of North America: Small Animal Practice 28, 361-375
18. INNES, J. (1995) Diagnosis and treatment of osteoarthritis in dogs. In Practice 17, 102-109
19. ISAACS, J P. (1996) Adverse effects of non-steroidal anti-inflammatory drugs in the dog and cat. Australian Veterinary Practitioner 26, 180-186
20. JOHNSTON, S. A. (1997) Osteoarthritis: joint anatomy, physiology and pathobiology. Veterinary Clinics of North America: Small Animal Practice 27, 699-723
21. JONES, A. C. & DOHERTY, M. (1992) The treatment of Osteoarthritis. British Journal of Clinical Pharmacology 33, 357-363
22. LEQUESNE, M. (1994) Symptomatic slow acting drugs in osteoarthritis: A novel therapeutic concept? Revue du Rhumatisme (English edition) 61, 75-79
23. LEQUESNE, M., BRANDT, K., BELLAMY, N., MOSKOWITZ, R., MENKES, C. J., PELLETIER, J-P. & ALTMAN, R. (1994) Guidelines for testing slow acting drugs in osteoarthritis Journal of Rheumatology 21 (Supplement 41), 65-73
24. MCLAUGHLIN, R. (2000) Management of chronic osteoarthritic pain. Veterinary Clinics of North America: Small Animal Practice 30, 933-949
25. MCNAMARA, P. S., SPENCER, D. V. M., JOHNSTON, S. A. & TODHUNTER, R. J. (1997) Slow acting, disease modifying osteoarthritis agents. Veterinary Clinics of North America: Small Animal Practice 27, 863-881
26. MANKIN, H. J., BRANDT, K. D. & SHULMAN, L. E. (1986) Workshop on etiopathogenesis of osteoarthritis, proceedings and recommendations. Journal of Rheumatology 13, 1126-1160
27. MATHEWS, K. (2000) Non-steroidal anti-inflammatory analgesics: indications and contraindications for pain management in dogs and cats. Veterinary Clinics of North America: Small Animal Practice 30, 783-804
28. PALMOSKI, M. J. & BRANDT, K. D. (1980) Effects of some nonsteroidal antiinflammatory drugs on proteogylcan metabolism and organisation m canine articular cartilage. Arthritis and Rheumatism 23, 1010-1020
29. READ, R. A , CULLIS-HILL, D. & JONES, M. P. (1996) Systemic use of pentosan polysulphate in the treatment of osteoarthritis. Journal of Small Animal Practice 37, 108-114
30. SILVERBERG, M. & DIEHL, S. V. (1987a) The autoactivation of Factor XII (Hageman factor) induced by low Mr heparin and dextran sulphate. Biochemical Journal 248, 715-720
31. SILVERBERG, M. & DIEHL, S. V. (1987b) The activation of the contact system of human plasma by polysaccharide sulfates. Annals of the New York Academy of Sciences 516, 268-279
32. SMITH, J. G., HANNON, R. L., BRUNNBERG, L., GEBSKI, V. & CULLIS-HILL, D. (2001) A randomised, double-blind, comparator controlled study of the efficacy of sodium pentosan polysulfate injections and carprofen capsules in arthritic dogs Osteoarthritis and Cartilage 9, Supplement B, 21
33. THEILER, R., GHOSH, P & BROOKS, P. (1994) Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity. Osteoarthritis and Cartilage 2, 1-23
34. TURNER, T. (1992) An assessment of Cartrophen Vet in practice Veterinary Practice 24, 6-9
35. VAUGHAN-SCOTT, T. & TAYLOR, J. H. (1997) The pathobiology and medical management of canine osteoarthritis. Journal of the South African Veterinary Association 68, 21-25
36. VETERINARY MEDICINES DIRECTORATE (1996) VMD Guidance Note AMELIA 12 - Marketing Authorisations for Veterinary Medicinal Products: Interim Guidance on Pharmacovigilance. pp 1-12